LENZ Extends Runway with $30M Investment
BIOTECH: Aims to Grow Team to 200 in 2025
By FRED GRIER
TABLE OF CONTENTS
DEL MAR – LENZ Therapeutics, a publicly traded biopharmaceutical firm helping millions of people improve their vision, has received a $30 million private investment from Ridgeback Capital.
The Del Mar-based company plans to use the new financing to...
Read latest San Diego Business Journal online.
Online newspapers
at PressDisplay.